First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer
Titel:
First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer
Auteur:
Chung, Vincent Heath, Elisabeth I. Schelman, William R. Johnson, Brendan M. Kirby, Lyndon C. Lynch, Kerlin M. Botbyl, Jeffrey D. Lampkin, Thomas A. Holen, Kyle D.